Current management and prognostic factors for adult ependymoma

References

• Oppenheim JS, Strauss RC, Mormino J et al Ependymomas of the third ventricle. Neurosurgery34, 350–353 (1994).
   PubMed Web of Science ®Google Scholar
• Centeno RS, Lee AA, Winter J et al Supratentorial ependymomas: neuroimaging and clinicopathological correlation. Neurosurg. 64, 209–215 (1986).
   Web of Science ®Google Scholar
• Healey EA, Barnes PD, Kupsky WJ et al The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery 28, 666–671 (1991).
   PubMed Web of Science ®Google Scholar
• McCormick PC, Stein BM. Intramedullary tumors in adults. Neurosurg. Gun. N Am. 1, 609–630 (1990).
   PubMedGoogle Scholar
• Nazar GB, Hoffman HJ, Becker LE et al. Infratentorial ependymomas in childhood prognostic factors and treatment. Neurosurg 72, 408–417 (1990).
   Web of Science ®Google Scholar
• Schiffer D, Chie A, Giordana MT et al Histologic prognostic factors in ependymoma. Childs Nerv. Syst. 7, 177–182 (1991).
   PubMed Web of Science ®Google Scholar
• Bergsagel DJ, Finegold MJ, Cutel J et al. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl. Merl 326, 988–993 (1992).
   Google Scholar
• Ledwicky JA, Garcea RL, Bergsagel DJ et al Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology212, 710–717 (1995).
   PubMed Web of Science ®Google Scholar
• Weggen S, Bayer TA, von Deimling A et al. Low frequency of SV40, JC and BK polyoma virus sequences in human medulloblastomas, meningiomas and ependymomas. Brain Path& 10, 85–92 (1999).
   Google Scholar
• Reuther FJ, Lohler J, Herms J et al Low incidence of SV40-like sequences in ependymal tumours. Pathol 195, 580–585 (2001).
   Web of Science ®Google Scholar
• Wiestler OD, Schiffer D, Coons SW et al. Ependymal tumours. In: World Health Organization Classification of Tumours. Pathology and Genetics. TUMOUIN of the Nervous System. Kleihues P, Cavenee WK (Eds.), 71–81 (2000).
   Google Scholar
• •A benchmark reporting a comprehensive analysis of recent achievements in epidemiology, etiology, pathology and biology of ependymomas.
   Google Scholar
• Schiffer D, Giordana MT Prognosis of ependymoma. Childs Nerv. Syst. 14, 357–361 (1998).
   PubMed Web of Science ®Google Scholar
• •A relevant contribution to a thoroughly understanding of histology and prognostic factors of ependymomas. The role of pseudopalisading necrosis and endothelial proliferation in predicting prognosis is criticized.
   Google Scholar
• Kimura T, Budka H, Soler F. An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (SNIP) in human brain tumors. Clin. Neuropathol 5, 21–27 (1986).
   Google Scholar
• Tabuchi K, Moriya Y, Furuta T et al. 5–100 protein in human glial tumours. Qualitative and quantitative studies. Acta Neurochir. Wien 65, 239–251 (1982).
   Google Scholar
• Mannoji H, Becker LE. Ependymal and choroid plexus tumors. Cytokeratin and GFAP expression. Cancer 61, 1377–1385 (1988).
   Google Scholar
• Ritter AM, Hess KR, McLendon RE et al. Ependymomas: MIB-1 proliferation index and survival. J Neurooncol 40, 51–57 (1998).
   PubMed Web of Science ®Google Scholar
• Sato K, Schauble B, Kleihues P et al. Infrequent alterations of the p15, p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumours. Int. J Cancer66, 305–308 (1996).
   Google Scholar
• Lamszus K, Lachenmeyer L, Heinemann U et al Molecular genetic alterations on chromosomes 11 and 22 in ependymomas. Int.j Cancer91, 803–808 (2001).
   Google Scholar
• Weremowicz S, Kupsky WJ, Morton CC et al Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma. Cancer Genet. Cytogenet. 61, 193–196 (1992).
   Google Scholar
• Nijssen PC, Deprez RII, Tijssen CC et al. Familial anaplastic ependymoma: evidence of loss of chromosome 22 in tumour cells. J Neural Neurosurg. Psychiatry 57, 1245–1248 (1994).
   Google Scholar
• Ward S, Harding B, Wilkins P et al Gain of lq and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma. Genes Chromosomes Cancer 32, 59–66 (2001).
   PubMed Web of Science ®Google Scholar
• Bijlsma EK, Voesten AM, Bijleveld EH et al Molecular analysis of genetic changes in ependymomas. Genes Chromosomes Cancer 13, 272–277 (1995).
   PubMed Web of Science ®Google Scholar
• Applegate GL, Marymont MET. Intracranial ependymomas: a review. Cancer Invest. 16, 588–593 (1998).
   PubMed Web of Science ®Google Scholar
• Metzger AK, Sheffield VC, Duyk G et al Identification of a germ line mutation in the p53 gene in a patient with an intracranial ependymoma. Proc. Natl Acad. Sci. USA 88, 7825–7829 (1991).
   Google Scholar
• Suzuki SO, Iwaki T Amplification and overexpression of mc/m2gene in ependymomas. Mod. Partial 13, 548–553 (2000).
   Google Scholar
• Birch BD, Johnson JP, Parsa A et al Frequent Type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas. Neurosurgery39, 135–140 (1996).
   PubMed Web of Science ®Google Scholar
• von Haken MS, White EC, Daneshvar S et al Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas. Genes Chromosomes Cancer 17, 37–44 (1996).
   PubMed Web of Science ®Google Scholar
• Ebert C, von Haken MS, Meyer-Puttlitz B et al Molecular genetic analysis of ependymal tumors: NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Am. Pathol 155, 627–632 (1999).
   Google Scholar
• Rousseau-Merck ME, Versteege I, Zattara- Cannoni H et al Fluorescence in situ hybridization determination of 22q12-q13 deletion in two intracerebral ependymomas. Cancer Genet. Cytogenet. 121, 223–227 (2000).
   Google Scholar
• Hirose Y, Aldape K, Bollen A et al Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. Ain.J. Athol 158, 1137–1143 (2001).
   PubMed Web of Science ®Google Scholar
• Prayson RA, Suh JH. Subependymomas: clinicopathologic study of 14 tumors, including comparative MIB-1 immunohistochemical analysis with other ependymal neoplasms. Arch. Athol Lab. Med. 123, 306–309 (1999).
   Google Scholar
• McLaughlin MP, Marcus RB, Buatti JM et al Ependymoma: results, prognostic factors and treatment recommendations. Int. J Radiat. aryl Biol. Phys. 40, 845–850 (1998).
   PubMed Web of Science ®Google Scholar
• Schild SE, Nisi K, Scheithauer BW et al The results of radiotherapy for ependymomas: the Mayo clinic experience. Int. J Radiat. aryl Biol. Phys. 42, 953–958 (1998).
   PubMed Web of Science ®Google Scholar
• Vanuytsel L, Brada M. The role of prophylactic spinal cord irradiation in localized intracranial ependymoma. Int. J Radiat. arca Biol. Phys. 21, 825–830 (1991).
   PubMed Web of Science ®Google Scholar
• •A critical review of the literature that defined the role of the extent of irradiation on the incidence of spinal metastases. Spinal irradiation did not influence the risk of seeding. The main risk factors were control of the tumor at the primary site, tumor localization and tumor grade.
   Google Scholar
• Salazar OM. A better understanding of CNS seeding and a brighter outlook for postoperatively irradiated patients with ependymomas. Int. J Radiat. aryl Biol. Phys. 9, 1231–1234 (1983).
   PubMed Web of Science ®Google Scholar
• Lyons MK, Kelly PJ. Posterior fossa ependymomas: report of 30 cases and review of the literature. Neurosurg. 28, 659–665 (1991).
   PubMed Web of Science ®Google Scholar
• Staben G, Stuschke M, Kroll M et al. Postoperative RT of spinal and intracranial ependymomas: analysis of prognostic factors. Radiother. Oncol 45, 3–10 (1997).
   PubMed Web of Science ®Google Scholar
• Prayson RA.Myxopapillary ependymomas: a clinocopathologic study of 14 cases including MIB-1 and p53 immunoreactivity. Mod. Athol 10, 304–310 (1997).
   Google Scholar
• Daumas-Duport C. Histologic grading of gliomas. Curt: Opin. Neural. Neurosurg. 5, 924–931 (1992).
   Google Scholar
• Schiffer D, Chie A, Cravioto H et al. Ependymoma: internal correlations among pathological signs: the anaplastic variant. Neurosurgety29, 206–210 (1991).
   PubMed Web of Science ®Google Scholar
• Robertson PL, Zeltzer PM, Boyett JM et al. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's cancer Group. I Neumsurg 88, 695–703 (1998).
   PubMed Web of Science ®Google Scholar
• Garrett PG, Simpson WJK. Ependymomas: results of radiation treatment. Int. j Racliat. Oncol Biol. Phys. 9, 1121–1124 (1983).
   PubMed Web of Science ®Google Scholar
• Di Marco A, Campostrini F, Pradella R et al Postoperative irradiation of brain ependymomas: analysis of 33 cases. Acta Oncol 27, 261–267 (1988).
   PubMed Web of Science ®Google Scholar
• Emestus RI, Schroder R, Stutzer H et al The clinical and prognostic relevance of grading in intracranial ependymomas. BE J. Neurosurg. 11,421–428 (1997).
   PubMed Web of Science ®Google Scholar
• Shaw EG, Evans RG, Scheitauer BW et al Postoperative RT in intracranial ependymoma in pediatric and adult patients. Int. J. Racliat. Oncol Biol. Phys. 13, 1457–1462 (1987).
   PubMed Web of Science ®Google Scholar
• West CR, Bruce DA, Duffner PK. Ependymomas: factors in clinical and diagnostic staging. Cancer 56, 1812–1816 (1985).
   PubMed Web of Science ®Google Scholar
• Ross GW, Rubinstein U. Lack of histopathological correlation of malignant ependymomas with postoperative survival. Neurosurg 70, 31 (1989).
   Web of Science ®Google Scholar
• Spagnoli D, Tomei G, Ceccarelli G et al. Combined treatment of fourth ventricle ependymomas: report of 26 cases. Surg. Neural. 54, 19–26 (2000).
   Google Scholar
• Pierre-Kahn A, Hirsch AF, Roux FX et al Intracranial ependymomas in childhood: survival and functional results of 47 cases. Childs Brain10, 145–156 (1983).
   PubMedGoogle Scholar
• Kovalic JJ, Flaris N, Grigsby PW et al Intracranial ependymoma long-term outcome, patterns of failure. I Neurooncol 15, 125–131 (1993).
   PubMed Web of Science ®Google Scholar
• Vanuytsel L, Bessell EM, Ashley SE et al Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy. Int. I Racliat. Oncol Biol. Phys. 23, 313–319 (1992).
   PubMed Web of Science ®Google Scholar
• Wallner KE, Wara WM, Sheline GE et al. Intracranial ependymomas: results of treatment with partial or whole brain irradiation without spinal irradiation. int. Racliat. Oncol Biol. Phis. 12, 1937–1941 (1986).
   PubMed Web of Science ®Google Scholar
• Paulino AC, Chen-Wen B. The significance of radiotherapy treatment duration in intracranial ependymoma. mt. I Racliat. Oncol Biol. Phys. 47, 585–589 (2000).
   PubMed Web of Science ®Google Scholar
• Korshunov A, Golanov A, Timirgaz V. Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases.J Neural Sci. 177, 72–82 (2000).
   Google Scholar
• Merchant TE, Haida T, Wang MET et al Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy. I Neurosurg. 86, 943–949 (1997).
   PubMed Web of Science ®Google Scholar
• Zulch KJ. Brain Tumours: Their Biology and Pathology. Springer-Verlag (Ed.) New York, NY, USA, 3, 258–276 (1986).
   Google Scholar
• Goldwein JW, Leahy JM, Packher RJ et al Intracranial ependymomas in children. int. Racliat. Oncol Biol. Phys. 19, 1497–1502 (1990).
   PubMed Web of Science ®Google Scholar
• Isaacson SR. Radiation therapy and the management of intramedullary spinal cord tumors. Neuro-Oncol 47, 231–238 (2000).
   Web of Science ®Google Scholar
• Rousseau P, Habrand JL, Sarrazin D et al Treatment of intracranial ependymomas of children. Int. I Racliat. Oncol Biol. Phys. 28, 381–386 (1993).
   Web of Science ®Google Scholar
• Jenkin D. Posterior fossa tumors in childhood: radiation treatment. Clin. Neurosurg. 30, 203–208 (1983).
   PubMedGoogle Scholar
• Hukin J, Epstein F, Lefton D et al Treatment of intracranial ependymoma by surgery alone. Perliatr. Neurosurg 29, 40–45 (1998).
   PubMed Web of Science ®Google Scholar
• Imhof HG, Hany M, Wiestler OD et al Long-term follow-up in 39 patients with an ependymoma after surgery and irradiation. Strahlenther. Onkol 9, 513–519 (1992).
   Google Scholar
• Waldrom JN, Laperriere NJ, Jaakkimainen L et al Spinal cord ependymomas: a retrospective analysis of 59 cases. int. Racliat. Oncol Biol. Phis. 27,223-229 (1993).
   Google Scholar
• Clover LL, Hazuka MB, Kinzie JJ. Spinal cord ependymomas treated with surgery and radiation therapy. A review of 11 cases. AinI Gun. Oncol 16, 350–353 (1993).
   Google Scholar
• Schwartz TH, McCormick PC. Intramedullary ependymomas: clinical presentation, surgical treatment strategies and prognosis. I Neurooncol 47, 211–218 (2000).
   PubMed Web of Science ®Google Scholar
• Perilongo G, Massimino M, Sotti G et al Analyses of prognostic factors in a retrospective series of 92 children with ependymoma: Italian Pediatric Neuro-Oncology Group. Merl Perliatr. Oncol 29, 79–85 (1997).
   Google Scholar
• •Reports the results of a multivariate analysis of prognostic factors in a large retrospective series of 92 children collected in seven Italian centers. Extent of surgery was identified as the most important predictor of survival, while radiotherapy, histology, tumor site and chemotherapy did not have a clear impact on survival.
   Google Scholar
• Mork SJ, Loken AC. Ependymoma. Cancer 40, 907–915 (1977).
   PubMed Web of Science ®Google Scholar
• Palma, L, Celli P, Mariottini A et al. The importance of surgery in supratentorial ependymomas. Long-term survival in a series of 23 cases. Child s Nerv. Syst. 16, 170–175 (2000).
   Google Scholar
• Davis C, Symon L. Posterior fossa ependymomas in adults. Acta Neurochir. 82,115–117 (1986).
   PubMed Web of Science ®Google Scholar
• Paulino AC. The local field in infratentorial ependymoma: does the entire posterior fossa need to be treated? int. I Racliat. Oncol Biol. Phys. 49, 757–761 (2001).
   PubMed Web of Science ®Google Scholar
• Karim ABMF, Afra D, Comu P et al Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer study 22845 with the Medical Research Council study BR04: an interim analysis. int. Racliat. Oncol Biol. Phys. 52, 316–324 (2002).
   Google Scholar
• Emestus RI, Wilke 0. Spinal metastases of intracranial ependymomas: four case report and review of the literature. Neurosurg. Rev 13, 147–154 (1990).
   Google Scholar
• Packer RJ, Schut L, Siegel KR. Dissemination of primary central nervous system tumors of childhood: incidence and clinical implications. Frog: Exp. Tumor Res. 30, 206–214 (1987).
   Google Scholar
• Salazar OM, Castro-Vita H, VanHoutte P et al Improved survival cases on intracranial ependymoma after radiation therapy: late report and recommendations. Neurosurg. 59, 652–659 (1983).
   Web of Science ®Google Scholar
• Marks JE, Adler SJ. A comparative study of ependymomas by site of origin. int. Radiat. Oncol Biol. Phys. 8, 37–43 (1982).
   PubMed Web of Science ®Google Scholar
• Merchant TE, Zhu Y, Thompson SJ et al Preliminary results from a Phase II trial of conformal radiation therapy for pediatric patients with localized low—grade astrocytoma and ependymoma. int. Radiat. Oncol Biol. Phys. 52, 325–332 (2002).
   PubMed Web of Science ®Google Scholar
• Aggarwal R, Yeung D, Kumar P et al Efficacy and feasibility of stereotactic radiosurgery in the primary management of unfavorable pediatric ependymoma. Radiother. amyl 43, 269–273 (1997).
   PubMed Web of Science ®Google Scholar
• Stafford SL, Pollock BE, Foote RL et al Stereotactic radiosurgery for recurrent ependymoma. Cancer 88, 870–875 (2000).
   PubMed Web of Science ®Google Scholar
• Jawahar A, Kondziolka D, Flickinger JC et al Adjuvant stereotactic radiosurgery for anaplastic ependymoma. Stereotact. Funct. Neurosurg 73, 23–30 (1999).
   PubMed Web of Science ®Google Scholar
• Evans AE, Anderson JR, Leflowitz-Boudreau et al Adjuvant chemotherapy of childhood posterior fossa ependymoma: craniospinal irradiation with or without adjuvant CCNU, vincristine and prednisone: a Childrens Cancer Group study. Med Pecliatr: Oncol. 27, 8–14 (1996).
   PubMedGoogle Scholar
• Bouffet E, Foreman N. Chemotherapy for intracranial ependymomas. Childs Nerv. Syst. 15, 563–570 (1999).
   PubMed Web of Science ®Google Scholar
• •A comprehensive review of the state of the art of chemotherapy in the management of children with intracranial ependymoma. The authors analyze the outcome of published Phase II studies and conclude that there is little evidence of chemotherapy activity in ependymomas. Cisplatin is identified as the most active agent.
   Google Scholar
• Duffner PK, Horowitz ME, Krischer JR Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl. Med 328, 1725–1731 (1993).
   PubMed Web of Science ®Google Scholar
• J, Muller HL, Berthold F et al Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT '88/89.Paediatr. 210, 227–233 (1998).
   Google Scholar
• Mason WP, Goldman S, Yates AJ et al Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma: a report of the Children's cancer Group. I Neurooncol 37, 135–143 (1998).
   PubMed Web of Science ®Google Scholar
• Grill J, Kalifa C, Doz F et al A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma: a Phase II study. Pecliatr. Neurosurg 25, 7–12 (1996).
   PubMed Web of Science ®Google Scholar
• Kadota RP, Stewart CF, Horn M et al Topotecan for the treatment of recurrent or progressive central nervous system tumors — a Pediatric Oncology Group Phase II study. Neurooncol 43, 43–47 (1999).
   PubMed Web of Science ®Google Scholar
• Rudà R, Costanza A, Nobile M et al Response of ependymomas to chemotherapy with temozolomide. Neurvoncol 3, 366 (2001) (Abstract 395).
   Google Scholar